Quetiapine For Sleep: What You Need To Know

is quetiapine used for sleep

Quetiapine is an antipsychotic drug that has been approved by the FDA for the treatment of schizophrenia and bipolar disorder. It is also used as a supplementary treatment for depression. Quetiapine has sedative effects and is sometimes prescribed off-label as a short-term sleep aid for insomnia. However, its efficacy and safety for this purpose are poorly documented, and there are potential risks associated with its use, including weight gain, metabolic disorders, and increased cognitive decline in people with dementia. While some studies have shown that quetiapine can increase total sleep time, others have found inconclusive results. As such, it is important to consult a physician before taking quetiapine for sleep.

Characteristics Values
Use of quetiapine for sleep disorders Widespread in Norway, Australia, New Zealand, the UK, Canada and the US
Efficacy Poorly documented, with only one randomised trial conducted
Safety Serious side effects, including weight gain, metabolic disorders, and increased risk of death in elderly patients
Dosage Typically 25-100 mg at bedtime
FDA approval Not approved to treat insomnia
Off-label use Prescribed as a short-term sleep aid due to its sedative effects
Effectiveness Inconclusive results from studies
Risks Cardiometabolic effects and potential for abuse
Recommended treatments for insomnia Traditional hypnotic drugs, sleep hygiene advice, and cognitive behavioural therapy

shunsleep

Quetiapine is not approved by the FDA to treat insomnia

Quetiapine is an atypical antipsychotic drug that causes drowsiness and sedation as side effects. While it is approved by the FDA to treat schizophrenia and bipolar disorder, it is not approved to treat insomnia. Quetiapine is sometimes prescribed off-label as a short-term sleep aid, but its long-term efficacy and safety as a sleep aid are uncertain.

The use of quetiapine to treat sleep disorders has become widespread in several countries, including Norway, Australia, New Zealand, and the United Kingdom, and the United States. Prescriptions for quetiapine as a sleep aid have increased significantly in Canada, with a 300% increase from 2005 to 2012 and a 10-fold increase in its use for sleep disorders. However, the efficacy of quetiapine as a sleep aid is poorly documented, and even low doses may have substantial side effects.

There is limited data on the safety of using low-dose quetiapine for insomnia, and potential safety concerns have been raised. Some of the side effects reported in clinical trials of quetiapine for insomnia include weight gain, metabolic disorders, and an increase in triglycerides. Quetiapine also presents serious risks to people with dementia, such as increased cognitive decline and death. In addition, quetiapine can cause orthostatic hypotension, especially in the elderly, which can lead to syncope and potentially life-threatening conditions.

While quetiapine may be effective in improving sleep in people with mental health disorders like schizophrenia, many clinicians and professional medical organizations do not recommend its use for insomnia due to safety concerns and uncertain effectiveness. There is a lack of high-quality research on the safety and effectiveness of quetiapine for insomnia, and it is not recommended as a first-line treatment for insomnia. Other treatments, such as cognitive behavioral therapy for insomnia (CBT-I), sleep hygiene advice, medication, supplements, and lifestyle changes, are recommended instead.

shunsleep

Quetiapine is prescribed off-label as a short-term sleep aid

Quetiapine is a second-generation antipsychotic drug approved for the treatment of schizophrenia and bipolar disorder. It is also used as a supplementary treatment for depression. Quetiapine is not approved by the Food and Drug Administration (FDA) to treat insomnia. However, due to its sedative effects, it is sometimes prescribed off-label as a short-term sleep aid.

The use of quetiapine to treat sleep disorders has become widespread in several countries, including Norway, Australia, New Zealand, and the United Kingdom, Canada, and the United States. Prescriptions for quetiapine as a sleep aid have increased significantly in these countries, including among children, adolescents, and the elderly. However, its efficacy and safety for this indication are poorly documented by clinical trials. Only one randomised controlled trial of its efficacy for primary insomnia has been conducted, with inconclusive results.

Quetiapine has sedating properties and can cause drowsiness and sedation as side effects. It is thought to increase total sleep time and reduce the time from being fully awake to falling asleep. However, there are potential safety concerns when using quetiapine for insomnia, especially in the elderly. Adverse events and discontinuation due to adverse events are common among quetiapine users. There is a risk of cardiometabolic effects and potential for abuse, as well as other side effects such as weight gain and metabolic disorders.

While quetiapine may be prescribed off-label as a short-term sleep aid, it is important to consult with a physician before taking this medication. There is a lack of research on the risks associated with taking quetiapine as a sleep aid, especially over the long term. Other treatments for insomnia, such as cognitive behavioural therapy, sleep hygiene advice, and medication approved for this indication, may be recommended instead.

Cooling Down to Sleep with an Ice Pack

You may want to see also

shunsleep

Quetiapine has sedative effects and can cause drowsiness

Quetiapine is a second-generation antipsychotic drug approved for the treatment of schizophrenia and bipolar disorder. It is also used as a supplementary treatment for depression. Quetiapine has sedative effects and can cause drowsiness, making it a popular off-label treatment for insomnia and other sleep disorders. However, it is important to note that quetiapine has not been approved by the Food and Drug Administration (FDA) to treat insomnia.

The use of quetiapine to treat sleep disorders has become widespread globally, including in Norway, Australia, New Zealand, and the United Kingdom, and the United States. Prescriptions for quetiapine as a sleep aid have increased significantly in these countries, with many people using it to manage insomnia and other sleep disturbances. Quetiapine is often prescribed at lower doses for sleep problems, typically ranging from 25 mg to 100 mg taken before bedtime.

The drug's sedative effects are attributed to its action on histamine receptors, specifically the H1 and 5-HT2C receptors at lower doses. This receptor activity in the brain can lead to drowsiness, sleepiness, and sedation. In studies of quetiapine, somnolence (a state of drowsiness) was reported in 18% to 57% of patients. It is important to note that quetiapine can also enhance or counter the side effects of substances like marijuana, cocaine, and heroin.

While quetiapine may help with sleep in the short term, there are concerns about its long-term effectiveness and safety. Some studies have shown that the improvement in sleep quality may not be sustained over time. Additionally, there is a risk of side effects, including weight gain, metabolic disorders, and increased cognitive decline in people with dementia. In one study, quetiapine was found to have a high incidence of side effects, with adverse effects twice as common as other second-generation antipsychotics.

Due to these potential risks, it is crucial to consult with a physician before taking quetiapine as a sleep aid. While it may provide temporary relief from insomnia, more research is needed to understand its long-term effects and safety profile when used for this purpose.

shunsleep

Quetiapine may have substantial side effects and safety concerns

Quetiapine is a second-generation antipsychotic drug approved for the treatment of schizophrenia and bipolar disorder, and as a supplementary treatment for depression. However, its use for treating insomnia and other sleep disorders has become widespread, despite its efficacy being poorly documented by clinical trials.

There are potential safety concerns when using quetiapine, even in low doses, and it may have substantial side effects. Its use can result in drowsiness, increased hunger, dizziness, and difficulty with movement. It can also cause orthostatic hypotension, especially in the elderly, which can lead to syncope (loss of consciousness), and in severe cases, may result in hip fractures, transient ischemic attacks, myocardial infarction, and even death.

Quetiapine may also increase the risk of death in older adults with mental health problems related to dementia. It can cause a serious heart problem, and the risk may be higher if taken alongside certain medications for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV. It is important to inform your doctor about all medications you are taking to avoid adverse drug interactions.

Other side effects of quetiapine include increased prolactin levels, which may make it difficult to get pregnant, and potential negative impacts on a newborn if taken during pregnancy. It can also pass into breast milk, so it is important to consult a healthcare provider if breastfeeding or planning to breastfeed.

Furthermore, quetiapine may cause sedation, which is generally considered undesirable outside of its use for treating insomnia. It can also enhance or counter the effects of substances like marijuana, cocaine, and heroin, leading to potential misuse and abuse.

Due to these concerns, the use of quetiapine for sleep disorders is not recommended, and other treatments such as sleep hygiene advice and cognitive behavioural therapy for insomnia (CBT-I) are advised.

Relora and Sleep: Dosage Recommendations

You may want to see also

shunsleep

Quetiapine prescriptions for sleep have increased in several countries

Quetiapine is a second-generation antipsychotic drug approved for the treatment of schizophrenia and bipolar disorder. It is also used as a supplementary treatment for depression. Quetiapine has sedative effects and is sometimes prescribed off-label as a short-term sleep aid, although it is not approved by the FDA for treating insomnia.

Despite the widespread use of low-dose quetiapine for insomnia, its efficacy and safety are poorly documented by clinical trials. Only one randomised trial of its efficacy for primary insomnia has been conducted, on 13 patients, with inconclusive results. An open, non-controlled study over six weeks with 18 patients with primary insomnia showed an improvement in some of the subjective sleep parameters, but the time to fall asleep was not reduced.

The use of quetiapine to treat sleep disturbances has also increased in other countries, such as Norway. In Norway, quetiapine has been prescribed in doses of 25–100 mg to treat insomnia in children, adolescents, and the elderly. However, there are concerns about the potential side effects and lack of efficacy data for using quetiapine for sleep.

While quetiapine can be effective in managing insomnia, its long-term efficacy and safety, especially in non-psychiatric subjects, remain unknown. It is important to consult with a physician before taking quetiapine for sleep, as there are risks associated with the medication, and other treatments for insomnia are available.

Frankincense Oil: A Natural Sleep Aid

You may want to see also

Frequently asked questions

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment